Gabriela Leuschner

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Deep Proteome Profiling Reveals Common Prevalence of MZB1-Positive Plasma B Cells in Human Lung and Skin Fibrosis

Herbert B. Schiller, Christoph H. Mayr, Gabriela Leuschner et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 119 citations

Life Sciences, Immunology, Pathology +17

Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers

Christoph H. Mayr, Lukas M. Simon, Gabriela Leuschner et al. · EMBO Molecular Medicine · 2021 · 103 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Structured reporting of CT examinations in acute pulmonary embolism

Bastian O. Sabel, Jessica L. Plum, Nikolaus Kneidinger et al. · Journal of cardiovascular computed tomography · 2017 · 60 citations

Medicine, Internal Medicine, Radiology +10

Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy

Gabriela Leuschner, Florian Stocker, Tobias Veit et al. · The Journal of Heart and Lung Transplantation · 2017 · 59 citations

Medicine, Surgery, Pulmonology +12